# RxSight (RXST) — Earnings

RXST · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/rxst/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2026 |
| Period end | Jun 30, 2026 |
| EPS actual | −$0.29 |
| EPS estimate | −$0.33 |
| EPS surprise | +11.96% |
| Revenue surprise | +3.66% |
| Revenue | $33.7M |
| Revenue estimate | $32.5M |
| Reported | Aug 5, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1111485/000119312526335153/rxst-20260630.htm) |
| Earnings call | [Transcript](http://o.thsi.cn/dc-d-stock-america.teleconference/06627bbc-eec6-6d82-5605-a937acb03151.html) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2026 | Aug 5, 2026 | −$0.33 | −$0.29 | 11.96% | $32.5M | $33.7M |
| Q1 2026 | May 6, 2026 | −$0.30 | −$0.38 | -27.13% | $29.8M | $30.9M |
| Q4 2025 | Feb 25, 2026 | −$0.33 | −$0.22 | 34.27% | $30.2M | $32.6M |
| Q3 2025 | Nov 5, 2025 | −$0.38 | −$0.24 | 36.12% | $25.3M | $30.3M |
| Q2 2025 | Aug 7, 2025 | −$0.25 | −$0.29 | -14.08% | $34.8M | $33.6M |
| Q1 2025 | May 7, 2025 | −$0.22 | −$0.20 | 7.71% | $38.1M | $37.9M |
| Q4 2024 | Feb 25, 2025 | −$0.17 | −$0.15 | 9.58% | $40.3M | $40.2M |
| Q3 2024 | Nov 7, 2024 | −$0.25 | −$0.16 | 35.04% | $35.1M | $35.3M |
| Q2 2024 | Aug 5, 2024 | −$0.22 | −$0.16 | 28.22% | $32.3M | $34.9M |
| Q1 2024 | May 6, 2024 | −$0.29 | −$0.25 | 15.05% | $27.6M | $29.5M |
| Q4 2023 | Feb 28, 2024 | −$0.37 | −$0.26 | 29.42% | $28.2M | $28.6M |
| Q3 2023 | Nov 9, 2023 | −$0.43 | −$0.35 | 19.22% | $20.6M | $22.2M |
| Q2 2023 | Aug 7, 2023 | −$0.47 | −$0.40 | 14.98% | $19.2M | $20.8M |
| Q1 2023 | May 9, 2023 | −$0.53 | −$0.42 | 20.75% | $16.3M | $17.5M |
| Q4 2022 | Mar 6, 2023 | −$0.75 | −$0.56 | 25.26% | $15.8M | $16.1M |
| Q3 2022 | Nov 7, 2022 | −$0.71 | −$0.61 | 14.57% | $11.0M | $12.6M |
| Q2 2022 | Aug 8, 2022 | −$0.67 | −$0.61 | 8.61% | $10.6M | $11.4M |
| Q1 2022 | May 5, 2022 | −$0.59 | −$0.64 | -8.14% | $7.3M | $8.9M |
| Q4 2021 | Mar 8, 2022 | −$0.61 | −$0.47 | 23.05% | $7.6M | $8.4M |
| Q3 2021 | Nov 10, 2021 | −$0.61 | −$0.65 | -6.61% | $5.2M | $5.8M |

## Frequently Asked Questions

### When did RxSight (RXST) last report earnings?

RxSight last reported on Aug 5, 2026, covering fiscal Q2 2026.

### Did RXST beat earnings estimates?

Yes. RxSight reported EPS of −$0.29 for Q2 2026 against a −$0.33 estimate — a 11.96% beat.

### How much revenue did RXST report last quarter?

RxSight reported $33.7M in revenue for Q2 2026, against a consensus estimate of $32.5M.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).